Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pioglitazone for NASH in Patients with IGT or T2DM
NCT00227110Phase 4Completed
- Sponsor
- UT Health San Antonio
- Start
- Oct 2002
- Primary completion
- Nov 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of pioglitazone in Nonalcoholic steatohepatitis (NASH), sponsored by UT Health San Antonio. Started Oct 2002; status: completed.
02
Drugs
pioglitazone
03
Conditions
Nonalcoholic steatohepatitis (NASH)
Beyond the preview
Go deeper on NCT00227110.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00227110.